Brief: Renovorx Increases U.S. Production Of Renovocath Devices To Meet Growing Demand From Oncology Community
16/04/2025 13:43
April 16 (Reuters) - RenovoRx Inc RNXT.O: RENOVORX INCREASES U.S. PRODUCTION OF RENOVOCATH® DEVICES TO MEET GROWING DEMAND FROM ONCOLOGY COMMUNITY Source text: ID:nBw8LqrlPa Further company coverage: RNXT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on RenovoRx
See all newsBrief: Renovorx Advances Tamp Into Borderline Resectable Pancreatic Cancer With First Patient Enrolled In Investigator-Initiated Prism-Tamp Trial
RenovoRx Inc reports results for the quarter ended June 30 - Earnings Summary
Oncology device maker RenovoRx's Q2 revenue surges, raises FY outlook
Brief: RenovoRx Q2 Net Income USD -2.911 Million
Brief: Renovorx Achieves Major Milestone With Full Enrollment In Phase Iii Tiger-Pac Trial For Locally Advanced Pancreatic Cancer